Grants and Contributions:
Title:
Support to COVID-19 Diagnostics
Agreement Number:
7429348 P009757003
Agreement Value:
$40,000,000.00
Agreement Date:
Mar 31, 2021 - Aug 31, 2023
Description:
This project builds on Canada’s funding to the Foundation for Innovative New Diagnostics (FIND) during COVID-19. The initial project aims at accelerate the roll-out of safe, affordable, and effective COVID-19 diagnostics in Low- and Lower-Middle Income Countries. This project supports FIND in using testing technologies developed during COVID-19 to expand the range of diseases detected with a single test. This includes other respiratory diseases, sexually transmitted infections, and Human papillomavirus (HPV)-based screening for cervical cancer. The project aims to increase testing for the most marginalized, including women, children, and vulnerable groups.
Project activities include: (1) supporting the development of more straightforward sample collection methods, including self-sampling; and (2) conducting in-country customer preference surveys and barrier-to-access surveys to guide the final development and introduction of tests.
Organization:
Global Affairs Canada
Expected Results:
The expected outcomes of this project include: (1) enhanced equitable access to near-patient, accurate, and affordable tests for critical women’s health needs; and (2) enhanced evidence to develop and introduce tests.
Location:
1202 Geneva, CH
Reference Number:
064-2024-2025-Q2-00442
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Type:
Not-for-profit organization or charity
Additional Information:
Amendment #2 reflects an increase in the value of the agreement
Amendment Date
Jan 30, 2023
Recipient's Operating Name:
Foundation for Innovative New Diagn
Recipient's Legal Name:
Foundation for Innovative New Diagn
Amendments: